Top

Published in:

01-11-2020 | Insulins

Nutrition in chronic heart failure patients: a systematic review

Author: Vittorio Emanuele Bianchi

Published in: Heart Failure Reviews | Issue 6/2020

Abstract

Nutrition is the primary source of energy production for myocardial contractility and to maintaining cardiac efficiency. Although many studies provided evidence of the benefits of nutritional intervention in chronic heart failure patients (CHF), these effects are not still completely understood. We searched in PubMed and Embase articles related to the following keywords: “chronic heart failure” with “diet,” “nutrition,” “insulin resistance,” and “caloric restriction.” Of the 975 retrieved articles, 20 have been selected. The primary endpoint was the left ventricular (LV) function and the secondary mortality rate in HF patients. Some studies showed that the Mediterranean diet (MedDiet) had a beneficial effect on cardiac function, while others did not find any positive impact. Nutritional supplements and hypercaloric intake had positive effects on underweight HF patients, while hypocaloric diet was beneficial in obese HF patients improving glucose control and cardiac function. The effect of MedDiet in HF patients showed conflicting results. Changes in the dietary pattern can reduce the evolution of HF, considering not only the quality of food but also the caloric intake. The discriminant factor to prescribe a diet regime in HF patients is represented by body mass index (BMI). A well-balanced caloric diet represents an effective therapy in overweight HF patients to reduce the mortality rate. Long-term studies evaluating cause-effect of energy and macronutrients intake on cardiac function in HF patients are necessary.

Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8(1):30–41. https://doi.org/10.1038/nrcardio.2010.165CrossRefPubMed

Shafie AA, Tan YP, Ng CH (2018) Systematic review of economic burden of heart failure. Heart Fail Rev 23(1):131–145. https://doi.org/10.1007/s10741-017-9661-0CrossRefPubMed

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force M, Document R (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18(8):891–975. https://doi.org/10.1002/ejhf.592CrossRefPubMed

Yancy CW, Januzzi JL Jr, Allen LA, Butler J, Davis LL, Fonarow GC, Ibrahim NE, Jessup M, Lindenfeld J, Maddox TM, Masoudi FA, Motiwala SR, Patterson JH, Walsh MN, Wasserman A (2018) 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol 71(2):201–230. https://doi.org/10.1016/j.jacc.2017.11.025CrossRefPubMed

Nadruz W Jr, West E, Santos M, Skali H, Groarke JD, Forman DE, Shah AM (2016) Heart failure and midrange ejection fraction: implications of recovered ejection fraction for exercise tolerance and outcomes. Circ Heart Fail 9(4):e002826. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002826CrossRefPubMed

Lam CSP, Voors AA, de Boer RA, Solomon SD, van Veldhuisen DJ (2018) Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J. https://doi.org/10.1093/eurheartj/ehy301

Conway MA, Allis J, Ouwerkerk R, Niioka T, Rajagopalan B, Radda GK (1991) Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet 338(8773):973–976. https://doi.org/10.1016/0140-6736(91)91838-lCrossRefPubMed

Sack MN, Kelly DP (1998) The energy substrate switch during development of heart failure: gene regulatory mechanisms (Review). Int J Mol Med 1(1):17–24. https://doi.org/10.3892/ijmm.1.1.17CrossRefPubMed

Taegtmeyer H, Sen S, Vela D (2010) Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann N Y Acad Sci 1188:191–198. https://doi.org/10.1111/j.1749-6632.2009.05100.xCrossRefPubMedPubMedCentral

10.

Park TS, Goldberg IJ (2012) Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure. Heart Fail Clin 8(4):633–641. https://doi.org/10.1016/j.hfc.2012.06.003CrossRefPubMedPubMedCentral

11.

Libby P, Maroko PR, Braunwald E (1975) The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion. Circulation 51(4):621–626. https://doi.org/10.1161/01.cir.51.4.621CrossRefPubMed

12.

Neglia D, De Caterina A, Marraccini P, Natali A, Ciardetti M, Vecoli C, Gastaldelli A, Ciociaro D, Pellegrini P, Testa R, Menichetti L, L'Abbate A, Stanley WC, Recchia FA (2007) Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 293(6):H3270–H3278. https://doi.org/10.1152/ajpheart.00887.2007CrossRefPubMed

13.

Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L (2005) Insulin resistance and risk of congestive heart failure. JAMA 294(3):334–341. https://doi.org/10.1001/jama.294.3.334CrossRefPubMed

14.

Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97(12):2859–2865. https://doi.org/10.1172/JCI118742CrossRefPubMedPubMedCentral

15.

Raher MJ, Thibault HB, Buys ES, Kuruppu D, Shimizu N, Brownell AL, Blake SL, Rieusset J, Kaneki M, Derumeaux G, Picard MH, Bloch KD, Scherrer-Crosbie M (2008) A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload. Am J Physiol Heart Circ Physiol 295(6):H2495–H2502. https://doi.org/10.1152/ajpheart.00139.2008CrossRefPubMedPubMedCentral

16.

Chess DJ, Xu W, Khairallah R, O'Shea KM, Kop WJ, Azimzadeh AM, Stanley WC (2008) The antioxidant tempol attenuates pressure overload-induced cardiac hypertrophy and contractile dysfunction in mice fed a high-fructose diet. Am J Physiol Heart Circ Physiol 295(6):H2223–H2230. https://doi.org/10.1152/ajpheart.00563.2008CrossRefPubMedPubMedCentral

17.

Funada J, Betts TR, Hodson L, Humphreys SM, Timperley J, Frayn KN, Karpe F (2009) Substrate utilization by the failing human heart by direct quantification using arterio-venous blood sampling. PLoS One 4(10):e7533. https://doi.org/10.1371/journal.pone.0007533CrossRefPubMedPubMedCentral

18.

Voros G, Ector J, Garweg C, Droogne W, Van Cleemput J, Peersman N, Vermeersch P, Janssens S (2018) Increased cardiac uptake of ketone bodies and free fatty acids in human heart failure and hypertrophic Left ventricular remodeling. Circ Heart Fail 11(12):e004953. https://doi.org/10.1161/CIRCHEARTFAILURE.118.004953CrossRefPubMed

19.

Aubert G, Martin OJ, Horton JL, Lai L, Vega RB, Leone TC, Koves T, Gardell SJ, Kruger M, Hoppel CL, Lewandowski ED, Crawford PA, Muoio DM, Kelly DP (2016) The failing heart relies on ketone bodies as a fuel. Circulation 133(8):698–705. https://doi.org/10.1161/CIRCULATIONAHA.115.017355CrossRefPubMedPubMedCentral

20.

Bedi KC Jr, Snyder NW, Brandimarto J, Aziz M, Mesaros C, Worth AJ, Wang LL, Javaheri A, Blair IA, Margulies KB, Rame JE (2016) Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure. Circulation 133(8):706–716. https://doi.org/10.1161/CIRCULATIONAHA.115.017545CrossRefPubMedPubMedCentral

21.

Duda MK, O'Shea KM, Lei B, Barrows BR, Azimzadeh AM, McElfresh TE, Hoit BD, Kop WJ, Stanley WC (2008) Low-carbohydrate/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction. J Card Fail 14(4):327–335. https://doi.org/10.1016/j.cardfail.2007.11.003CrossRefPubMedPubMedCentral

22.

Okere IC, Chess DJ, McElfresh TA, Johnson J, Rennison J, Ernsberger P, Hoit BD, Chandler MP, Stanley WC (2005) High-fat diet prevents cardiac hypertrophy and improves contractile function in the hypertensive dahl salt-sensitive rat. Clin Exp Pharmacol Physiol 32(10):825–831. https://doi.org/10.1111/j.1440-1681.2005.04272.xCrossRefPubMed

23.

Christopher BA, Huang HM, Berthiaume JM, McElfresh TA, Chen X, Croniger CM, Muzic RF Jr, Chandler MP (2010) Myocardial insulin resistance induced by high fat feeding in heart failure is associated with preserved contractile function. Am J Physiol Heart Circ Physiol 299(6):H1917–H1927. https://doi.org/10.1152/ajpheart.00687.2010CrossRefPubMedPubMedCentral

24.

Harmancey R, Lam TN, Lubrano GM, Guthrie PH, Vela D, Taegtmeyer H (2012) Insulin resistance improves metabolic and contractile efficiency in stressed rat heart. FASEB J 26(8):3118–3126. https://doi.org/10.1096/fj.12-208991CrossRefPubMedPubMedCentral

25.

Rennison JH, McElfresh TA, Okere IC, Vazquez EJ, Patel HV, Foster AB, Patel KK, Chen Q, Hoit BD, Tserng KY, Hassan MO, Hoppel CL, Chandler MP (2007) High-fat diet postinfarction enhances mitochondrial function and does not exacerbate left ventricular dysfunction. Am J Physiol Heart Circ Physiol 292(3):H1498–H1506. https://doi.org/10.1152/ajpheart.01021.2006CrossRefPubMed

26.

Miro O, Estruch R, Martin-Sanchez FJ, Gil V, Jacob J, Herrero-Puente P, Herrera Mateo S, Aguirre A, Andueza JA, Llorens P, Group I-SR (2018) Adherence to Mediterranean diet and all-cause mortality after an episode of acute heart failure: results of the MEDIT-AHF study. JACC Heart Fail 6(1):52–62. https://doi.org/10.1016/j.jchf.2017.09.020CrossRef

27.

Zhou H, Qian H (2018) Relationship between enteral nutrition and serum levels of inflammatory factors and cardiac function in elderly patients with heart failure. Clin Interv Aging 13:397–401. https://doi.org/10.2147/CIA.S157507CrossRefPubMedPubMedCentral

28.

Gonzalez-Islas D, Orea-Tejeda A, Castillo-Martinez L, Olvera-Mayorga G, Rodriguez-Garcia WD, Santillan-Diaz C, Keirnes-Davis C, Vaquero-Barbosa N (2017) The effects of a low-carbohydrate diet on oxygen saturation in heart failure patients: a randomized controlled clinical trial. Nutr Hosp 34(4):792–798. https://doi.org/10.20960/nh.784CrossRefPubMed

29.

Papadaki A, Martinez-Gonzalez MA, Alonso-Gomez A, Rekondo J, Salas-Salvado J, Corella D, Ros E, Fito M, Estruch R, Lapetra J, Garcia-Rodriguez A, Fiol M, Serra-Majem L, Pinto X, Ruiz-Canela M, Bullo M, Serra-Mir M, Sorli JV, Aros F (2017) Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial. Eur J Heart Fail 19(9):1179–1185. https://doi.org/10.1002/ejhf.750CrossRefPubMed

30.

Deutz NE, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, Hegazi RA, Tappenden KA, Ziegler TR, Group NS (2016) Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clin Nutr 35(1):18–26. https://doi.org/10.1016/j.clnu.2015.12.010CrossRefPubMed

31.

Bonilla-Palomas JL, Gamez-Lopez AL, Castillo-Dominguez JC, Moreno-Conde M, Lopez Ibanez MC, Alhambra Exposito R, Ramiro Ortega E, Anguita-Sanchez MP, Villar-Raez A (2016) Nutritional intervention in malnourished hospitalized patients with heart failure. Arch Med Res 47(7):535–540. https://doi.org/10.1016/j.arcmed.2016.11.005CrossRefPubMed

32.

Kitzman DW, Haykowsky MJ, Kraus W (2016) Diet and exercise for obese patients with heart failure--reply. JAMA 315(23):2619–2620. https://doi.org/10.1001/jama.2016.2924CrossRefPubMed

33.

Tektonidis TG, Akesson A, Gigante B, Wolk A, Larsson SC (2016) Adherence to a Mediterranean diet is associated with reduced risk of heart failure in men. Eur J Heart Fail 18(3):253–259. https://doi.org/10.1002/ejhf.481CrossRefPubMed

34.

Wirth J, di Giuseppe R, Boeing H, Weikert C (2016) A Mediterranean-style diet, its components and the risk of heart failure: a prospective population-based study in a non-Mediterranean country. Eur J Clin Nutr 70(9):1015–1021. https://doi.org/10.1038/ejcn.2016.140CrossRefPubMed

35.

Colin-Ramirez E, Castillo-Martinez L, Orea-Tejeda A, Zheng Y, Westerhout CM, Ezekowitz JA (2014) Dietary fatty acids intake and mortality in patients with heart failure. Nutrition 30(11-12):1366–1371. https://doi.org/10.1016/j.nut.2014.04.006CrossRefPubMed

36.

McKeag NA, McKinley MC, Harbinson MT, Noad RL, Dixon LH, McGinty A, Neville CE, Woodside JV, McKeown PP (2014) The effect of multiple micronutrient supplementation on left ventricular ejection fraction in patients with chronic stable heart failure: a randomized, placebo-controlled trial. JACC Heart Fail 2(3):308–317. https://doi.org/10.1016/j.jchf.2013.12.008CrossRefPubMed

37.

Levitan EB, Lewis CE, Tinker LF, Eaton CB, Ahmed A, Manson JE, Snetselaar LG, Martin LW, Trevisan M, Howard BV, Shikany JM (2013) Mediterranean and DASH diet scores and mortality in women with heart failure: the Women's Health Initiative. Circ Heart Fail 6(6):1116–1123. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000495CrossRefPubMedPubMedCentral

38.

Motie M, Evangelista LS, Horwich T, Hamilton M, Lombardo D, Cooper DM, Galassetti PR, Fonarow GC (2013) Pro-HEART - a randomized clinical trial to test the effectiveness of a high protein diet targeting obese individuals with heart failure: rationale, design and baseline characteristics. Contemp Clin Trials 36(2):371–381. https://doi.org/10.1016/j.cct.2013.08.004CrossRefPubMed

39.

Nguyen HT, Bertoni AG, Nettleton JA, Bluemke DA, Levitan EB, Burke GL (2012) DASH eating pattern is associated with favorable left ventricular function in the multi-ethnic study of atherosclerosis. J Am Coll Nutr 31(6):401–407. https://doi.org/10.1080/07315724.2012.10720466CrossRefPubMedPubMedCentral

40.

Rozentryt P, von Haehling S, Lainscak M, Nowak JU, Kalantar-Zadeh K, Polonski L, Anker SD (2010) The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study. J Cachexia Sarcopenia Muscle 1(1):35–42. https://doi.org/10.1007/s13539-010-0008-0CrossRefPubMedPubMedCentral

41.

Chrysohoou C, Panagiotakos DB, Aggelopoulos P, Kastorini CM, Kehagia I, Pitsavos C, Stefanadis C (2010) The Mediterranean diet contributes to the preservation of left ventricular systolic function and to the long-term favorable prognosis of patients who have had an acute coronary event. Am J Clin Nutr 92(1):47–54. https://doi.org/10.3945/ajcn.2009.28982CrossRefPubMed

42.

Liu L, Nettleton JA, Bertoni AG, Bluemke DA, Lima JA, Szklo M (2009) Dietary pattern, the metabolic syndrome, and left ventricular mass and systolic function: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr 90(2):362–368. https://doi.org/10.3945/ajcn.2009.27538CrossRefPubMedPubMedCentral

43.

Levitan EB, Wolk A, Mittleman MA (2009) Consistency with the DASH diet and incidence of heart failure. Arch Intern Med 169(9):851–857. https://doi.org/10.1001/archinternmed.2009.56CrossRefPubMedPubMedCentral

44.

Aquilani R, Viglio S, Iadarola P, Opasich C, Testa A, Dioguardi FS, Pasini E (2008) Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure. Am J Cardiol 101(11A):104E–110E. https://doi.org/10.1016/j.amjcard.2008.03.008CrossRefPubMed

45.

Colin Ramirez E, Castillo Martinez L, Orea Tejeda A, Rebollar Gonzalez V, Narvaez David R, Asensio Lafuente E (2004) Effects of a nutritional intervention on body composition, clinical status, and quality of life in patients with heart failure. Nutrition 20(10):890–895. https://doi.org/10.1016/j.nut.2004.06.010CrossRefPubMed

46.

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097CrossRefPubMedPubMedCentral

47.

Aquilani R, Opasich C, Gualco A, Verri M, Testa A, Pasini E, Viglio S, Iadarola P, Pastoris O, Dossena M, Boschi F (2008) Adequate energy-protein intake is not enough to improve nutritional and metabolic status in muscle-depleted patients with chronic heart failure. Eur J Heart Fail 10(11):1127–1135. https://doi.org/10.1016/j.ejheart.2008.09.002CrossRefPubMed

48.

Feinberg J, Nielsen EE, Korang SK, Halberg Engell K, Nielsen MS, Zhang K, Didriksen M, Lund L, Lindahl N, Hallum S, Liang N, Xiong W, Yang X, Brunsgaard P, Garioud A, Safi S, Lindschou J, Kondrup J, Gluud C, Jakobsen JC (2017) Nutrition support in hospitalised adults at nutritional risk. Cochrane Database Syst Rev 5:CD011598. https://doi.org/10.1002/14651858.CD011598.pub2CrossRefPubMed

49.

Kerley CP (2019) Dietary patterns and components to prevent and treat heart failure: a comprehensive review of human studies. Nutr Res Rev 32(1):1–27. https://doi.org/10.1017/S0954422418000148CrossRefPubMed

50.

Butler T (2016) Dietary management of heart failure: room for improvement? Br J Nutr 115(7):1202–1217. https://doi.org/10.1017/S000711451500553XCrossRefPubMed

51.

De Schutter A, Lavie CJ, Kachur S, Patel DA, Milani RV (2014) Body composition and mortality in a large cohort with preserved ejection fraction: untangling the obesity paradox. Mayo Clin Proc 89(8):1072–1079. https://doi.org/10.1016/j.mayocp.2014.04.025CrossRefPubMed

52.

Clark AL, Chyu J, Horwich TB (2012) The obesity paradox in men versus women with systolic heart failure. Am J Cardiol 110(1):77–82. https://doi.org/10.1016/j.amjcard.2012.02.050CrossRefPubMedPubMedCentral

53.

Sze S, Pellicori P, Zhang J, Clark AL (2018) Malnutrition, congestion and mortality in ambulatory patients with heart failure. Heart. https://doi.org/10.1136/heartjnl-2018-313312

54.

Weijs PJM, Wolfe RR (2016) Exploration of the protein requirement during weight loss in obese older adults. Clin Nutr 35(2):394–398. https://doi.org/10.1016/j.clnu.2015.02.016CrossRefPubMed

55.

von Haehling S, Ebner N, Dos Santos MR, Springer J, Anker SD (2017) Muscle wasting and cachexia in heart failure: mechanisms and therapies. Nat Rev Cardiol 14(6):323–341. https://doi.org/10.1038/nrcardio.2017.51CrossRef

56.

Sharma A, Lavie CJ, Borer JS, Vallakati A, Goel S, Lopez-Jimenez F, Arbab-Zadeh A, Mukherjee D, Lazar JM (2015) Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol 115(10):1428–1434. https://doi.org/10.1016/j.amjcard.2015.02.024CrossRefPubMed

57.

Abi Khalil C, Sulaiman K, Singh R, Jayyousi A, Asaad N, AlHabib KF, Alsheikh-Ali A, Al-Jarallah M, Bulbanat B, AlMahmeed W, Dargham S, Ridha M, Bazargani N, Amin H, Al-Motarreb A, AlFaleh H, Elasfar A, Panduranga P, Al Suwaidi J (2017) BMI is inversely correlated to the risk of mortality in patients with type 2 diabetes hospitalized for acute heart failure: findings from the Gulf aCute heArt failuRE (Gulf-CARE) registry. Int J Cardiol 241:262–269. https://doi.org/10.1016/j.ijcard.2017.02.119CrossRefPubMed

58.

Matsushita M, Shirakabe A, Hata N, Shinada T, Kobayashi N, Tomita K, Tsurumi M, Okazaki H, Yamamoto Y, Asai K, Shimizu W (2017) Association between the body mass index and the clinical findings in patients with acute heart failure: evaluation of the obesity paradox in patients with severely decompensated acute heart failure. Heart Vessel 32(5):600–608. https://doi.org/10.1007/s00380-016-0908-9CrossRef

59.

Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH (2001) The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38(3):789–795. https://doi.org/10.1016/s0735-1097(01)01448-6CrossRefPubMed

60.

Rayner JJ, Neubauer S, Rider OJ (2015) The paradox of obesity cardiomyopathy and the potential for weight loss as a therapy. Obes Rev 16(8):679–690. https://doi.org/10.1111/obr.12292CrossRefPubMed

61.

Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB (2008) Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 29(21):2641–2650. https://doi.org/10.1093/eurheartj/ehn420CrossRefPubMed

62.

Song EK, Lee Y, Moser DK, Dekker RL, Kang SM, Lennie TA (2014) The link of unintentional weight loss to cardiac event-free survival in patients with heart failure. J Cardiovasc Nurs 29(5):439–447. https://doi.org/10.1097/JCN.0b013e3182a46ba8CrossRefPubMedPubMedCentral

63.

Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, Clemenza F, Tognoni G, Anand IS, Cohn JN, Anker SD, Tavazzi L, Latini R, Gissi HF, Val-He FTI (2015) Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur J Heart Fail 17(4):424–433. https://doi.org/10.1002/ejhf.240CrossRefPubMed

64.

Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361(9363):1077–1083. https://doi.org/10.1016/S0140-6736(03)12892-9CrossRefPubMed

65.

Zamora E, Diez-Lopez C, Lupon J, de Antonio M, Domingo M, Santesmases J, Troya MI, Diez-Quevedo C, Altimir S, Bayes-Genis A (2016) Weight loss in obese patients with heart failure. J Am Heart Assoc 5(3):e002468. https://doi.org/10.1161/JAHA.115.002468CrossRefPubMedPubMedCentral

66.

De Stefani FDC, Pietraroia PS, Fernandes-Silva MM, Faria-Neto J, Baena CP (2018) Observational evidence for unintentional weight loss in all-cause mortality and major cardiovascular events: a systematic review and meta-analysis. Sci Rep 8(1):15447. https://doi.org/10.1038/s41598-018-33563-zCrossRefPubMedPubMedCentral

67.

Look ARG, Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Clark JM, Coday M, Curtis JM, Egan C, Evans M, Foreyt J, Foster G, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jeffery RW, Johnson KC, Kitabchi AE, Knowler WC, Kriska A, Lang W, Lewis CE, Montez MG, Nathan DM, Neiberg RH, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Redmon B, Regensteiner J, Rejeski J, Ribisl PM, Safford M, Stewart K, Trence D, Wadden TA, Wing RR, Yanovski SZ (2016) Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol 4(11):913–921. https://doi.org/10.1016/S2213-8587(16)30162-0CrossRef

68.

Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal A, Cederholm T, Cruz-Jentoft A, Krznaric Z, Nair KS, Singer P, Teta D, Tipton K, Calder PC (2014) Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr 33(6):929–936. https://doi.org/10.1016/j.clnu.2014.04.007CrossRefPubMedPubMedCentral

69.

Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N, Loncar G, Springer J, Doehner W, Lainscak M, Hasenfuss G, Anker SD, von Haehling S (2018) Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur J Heart Fail 20(11):1580–1587. https://doi.org/10.1002/ejhf.1304CrossRefPubMed

70.

Lavie CJ, Sharma A, Alpert MA, De Schutter A, Lopez-Jimenez F, Milani RV, Ventura HO (2016) Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis 58(4):393–400. https://doi.org/10.1016/j.pcad.2015.12.003CrossRefPubMed

71.

Deger SM, Hewlett JR, Gamboa J, Ellis CD, Hung AM, Siew ED, Mamnungu C, Sha F, Bian A, Stewart TG, Abumrad NN, Ikizler TA (2018) Insulin resistance is a significant determinant of sarcopenia in advanced kidney disease. Am J Physiol Endocrinol Metab 315(6):E1108–E1120. https://doi.org/10.1152/ajpendo.00070.2018CrossRefPubMedPubMedCentral

72.

McDowell K, Petrie MC, Raihan NA, Logue J (2018) Effects of intentional weight loss in patients with obesity and heart failure: a systematic review. Obes Rev. https://doi.org/10.1111/obr.12707

73.

Sung MM, Dyck JR (2012) Age-related cardiovascular disease and the beneficial effects of calorie restriction. Heart Fail Rev 17(4-5):707–719. https://doi.org/10.1007/s10741-011-9293-8CrossRefPubMed

74.

Granado M, Amor S, Martin-Carro B, Guerra-Menendez L, Tejera-Munoz A, Gonzalez-Hedstrom D, Rubio C, Carrascosa JM, Garcia-Villalon AL (2019) Caloric restriction attenuates aging-induced cardiac insulin resistance in male Wistar rats through activation of PI3K/Akt pathway. Nutr Metab Cardiovasc Dis 29(1):97–105. https://doi.org/10.1016/j.numecd.2018.09.005CrossRefPubMed

75.

Le T, Flatt SW, Natarajan L, Pakiz B, Quintana EL, Heath DD, Rana BK, Rock CL (2016) Effects of diet composition and insulin resistance status on plasma lipid levels in a weight loss intervention in women. J Am Heart Assoc 5(1). https://doi.org/10.1161/JAHA.115.002771

76.

Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HW, Lubberink M, Romijn JA, Bax JJ, de Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JW, Diamant M (2009) Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol 54(16):1524–1532. https://doi.org/10.1016/j.jacc.2009.04.074CrossRefPubMed

77.

Waldman M, Cohen K, Yadin D, Nudelman V, Gorfil D, Laniado-Schwartzman M, Kornwoski R, Aravot D, Abraham NG, Arad M, Hochhauser E (2018) Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1alpha'. Cardiovasc Diabetol 17(1):111. https://doi.org/10.1186/s12933-018-0754-4CrossRefPubMedPubMedCentral

78.

Yan L, Gao S, Ho D, Park M, Ge H, Wang C, Tian Y, Lai L, De Lorenzo MS, Vatner DE, Vatner SF (2013) Calorie restriction can reverse, as well as prevent, aging cardiomyopathy. Age (Dordr) 35(6):2177–2182. https://doi.org/10.1007/s11357-012-9508-5CrossRef

79.

Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1(7285):785–789CrossRef

80.

Luptak I, Balschi JA, Xing Y, Leone TC, Kelly DP, Tian R (2005) Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization. Circulation 112(15):2339–2346. https://doi.org/10.1161/CIRCULATIONAHA.105.534594CrossRefPubMed

81.

Brambilla A, Mannarino S, Pretese R, Gasperini S, Galimberti C, Parini R (2014) Improvement of cardiomyopathy after high-fat diet in two siblings with glycogen storage disease type III. JIMD Rep 17:91–95. https://doi.org/10.1007/8904_2014_343CrossRefPubMedPubMedCentral

82.

Emelyanova L, Boukatina A, Myers C, Oyarzo J, Lustgarten J, Shi Y, Jahangir A (2019) High calories but not fat content of lard-based diet contribute to impaired mitochondrial oxidative phosphorylation in C57BL/6 J mice heart. PLoS One 14(7):e0217045. https://doi.org/10.1371/journal.pone.0217045CrossRefPubMedPubMedCentral

83.

Haufe S, Utz W, Engeli S, Kast P, Bohnke J, Pofahl M, Traber J, Haas V, Hermsdorf M, Mahler A, Busjahn A, Wiesner S, Otto C, Mehling H, Luft FC, Boschmann M, Schulz-Menger J, Jordan J (2012) Left ventricular mass and function with reduced-fat or reduced-carbohydrate hypocaloric diets in overweight and obese subjects. Hypertension 59(1):70–75. https://doi.org/10.1161/HYPERTENSIONAHA.111.178616CrossRefPubMed

Title: Nutrition in chronic heart failure patients: a systematic review
Author: Vittorio Emanuele Bianchi
Publication date: 01-11-2020
Publisher: Springer US
Keywords: Insulins
Nutrition
Chronic Heart Failure
Insulins
Published in: Heart Failure Reviews / Issue 6/2020
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-019-09891-1

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Nutrition in chronic heart failure patients: a systematic review

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2020

Economic evaluation of the utilization of telemedicine for patients with cardiovascular disease: a systematic review

Survival outcomes of stenting outflow graft stenosis in continuous-flow left ventricular assist devices: a systematic review

A manifesto of collaborative longitudinal cardiovascular care in heart failure

Cavitation in left ventricular assist device patients: a potential early sign of pump thrombosis

Non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world data

Long non-coding RNAs in cardiac hypertrophy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page